ScholarIQanswers from OpenAlex
Optimizing bevacizumab dosing in glioblastoma: less is more
PaperCitations, authors & open-access status
Optimizing bevacizumab dosing in glioblastoma: less is more is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Optimizing bevacizumab dosing in glioblastoma: less is more have?
ScholarIQcitation count
Optimizing bevacizumab dosing in glioblastoma: less is more has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Optimizing bevacizumab dosing in glioblastoma: less is more published?
ScholarIQyear
Optimizing bevacizumab dosing in glioblastoma: less is more has 2017 year in the ScholarIQ index.
What is the open-access status of Optimizing bevacizumab dosing in glioblastoma: less is more?
ScholarIQoa status
Optimizing bevacizumab dosing in glioblastoma: less is more has closed oa status in the ScholarIQ index.
What is the DOI of Optimizing bevacizumab dosing in glioblastoma: less is more?
ScholarIQdoi
The DOI for Optimizing bevacizumab dosing in glioblastoma: less is more is on the source record.
What is the PMID of Optimizing bevacizumab dosing in glioblastoma: less is more?
ScholarIQpmid
The PMID for Optimizing bevacizumab dosing in glioblastoma: less is more is on the source record.
What is the OpenAlex record for Optimizing bevacizumab dosing in glioblastoma: less is more?
ScholarIQopenalex
The OpenAlex for Optimizing bevacizumab dosing in glioblastoma: less is more is on the source record.